Matt Murphy
Manager of Investor Relations, CARA Therapeutics
Replay available
Cara Therapeutics, Inc. (CARA) Q4 2022 Earnings Call
Cara Therapeutics, Inc. (NASDAQ: CARA) Q4 2022 earnings conference call, held 2023-03-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
AJ Velasquez-Mao
Analyst, Jefferies
Jason Gerberry
Analyst, Bank of America
Joseph Schringer
Analyst, Needham and Company
Chris Posner
Chief Executive Officer, CARA Therapeutics
Annabelle Samumi
Analyst, CIFL
Oren Livnat
Analyst, H.G. Wainwright
Dr. Joanna Consalves
Chief Medical Officer, CARA Therapeutics
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Tvardi Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:03.890 Good afternoon. My name is Josh and I will be your conference facilitator. 00:00:03.890 -- 00:00:07.741 I would like to welcome everyone to the CARA Therapeutics fourth quarter and full year 00:00:07.741 -- 00:00:09.172 2022 00:00:09.172 -- 00:00:11.933 financial results and update conference call. 00:00:11.933 -- 00:00:15.334 All lines have been placed on mute to avoid any background noise. 00:00:15.334 -- 00:00:18.655 After the speaker's remarks, there will be a question and answer session. 00:00:18.655 -- 00:00:22.766 If you would like to ask a question during this time, simply press star and the number 00:00:22.766 -- 00:00:27.957 11 on your telephone keypad. Please be advised that this call is being recorded. 00:00:27.957 -- 00:00:33.357 I would now like to introduce Matt Murphy, CARA's Manager of Investor Relations. 00:00:33.357 -- 00:00:36.778 Mr. Murphy, you may begin your call. 00:00:37.160 -- 00:00:39.943 Thank you, Operator, and good afternoon. 00:00:39.943 -- 00:00:44.427 Just after market closed today, CARA issued a news release announcing the company's results 00:00:44.427 -- 00:00:47.998 for the fourth quarter and full year 2022. 00:00:48.070 -- 00:00:52.894 Copies of this news release and the associated SEC filing can be found in the investor 00:00:52.894 -- 00:00:56.856 section of our website at www.caratherapeutics.com. 00:00:58.137 -- 00:01:02.198 Before we begin, let me remind you that during the course of this conference call, we 00:01:02.198 -- 00:01:06.919 will be making certain forward-looking statements about CARA and our programs based on 00:01:06.919 -- 00:01:09.860 management's current plans and expectations. 00:01:09.860 -- 00:01:13.831 These statements are being made under the Private Securities Litiga...